122 related articles for article (PubMed ID: 9639415)
1. CD34+/CD36- cells from myelodysplasia patients have a limited capacity to proliferate but can differentiate in response to Epo and MGF stimulation.
Brada SJ; de Wolf JT; Hendriks DW; Smit JW; Vellenga E
Leukemia; 1998 Jun; 12(6):882-6. PubMed ID: 9639415
[TBL] [Abstract][Full Text] [Related]
2. The supportive effects of erythropoietin and mast cell growth factor on CD34+/CD36- sorted bone marrow cells of myelodysplasia patients.
Brada S; de Wolf J; Hendriks D; Esselink M; Ruiters M; Vellenga E
Blood; 1996 Jul; 88(2):505-10. PubMed ID: 8695798
[TBL] [Abstract][Full Text] [Related]
3. Mast cell growth factor modulates CD36 antigen expression on erythroid progenitors from human bone marrow and peripheral blood associated with ongoing differentiation.
de Wolf JT; Muller EW; Hendriks DH; Halie RM; Vellenga E
Blood; 1994 Jul; 84(1):59-64. PubMed ID: 7517219
[TBL] [Abstract][Full Text] [Related]
4. Growth analysis of marrow CD34-positive hematopoietic progenitor cells in patients with myelodysplastic syndromes.
Asano H; Hotta T; Ichihara M; Murate T; Kobayashi M; Saito H
Leukemia; 1994 May; 8(5):833-8. PubMed ID: 7514249
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
6. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
[TBL] [Abstract][Full Text] [Related]
7. The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes.
Verbeek W; Vehmeyer K; Wörmann B; Hiddemann W
J Cancer Res Clin Oncol; 1995; 121(6):338-42. PubMed ID: 7797598
[TBL] [Abstract][Full Text] [Related]
8. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
9. Human interleukin (IL)-9 specifically stimulates proliferation of CD34+++DR+CD33- erythroid progenitors in normal human bone marrow in the absence of serum.
Lu L; Leemhuis T; Srour EF; Yang YC
Exp Hematol; 1992 May; 20(4):418-24. PubMed ID: 1373687
[TBL] [Abstract][Full Text] [Related]
10. An improved serum free system for cloning human "pure" erythroid colonies. The role of different growth factors and cytokines on BFU-E formation by the bone marrow and cord blood CD34+ cells.
Ratajczak J; Marlicz W; Machaliński B; Pertusini E; Czajka R; Ratajczak MZ
Folia Histochem Cytobiol; 1998; 36(2):55-60. PubMed ID: 9606618
[TBL] [Abstract][Full Text] [Related]
11. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro.
von Lindern M; Zauner W; Mellitzer G; Steinlein P; Fritsch G; Huber K; Löwenberg B; Beug H
Blood; 1999 Jul; 94(2):550-9. PubMed ID: 10397722
[TBL] [Abstract][Full Text] [Related]
12. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin.
Aoki I; Taniyama M; Toyama K; Homori M; Ishikawa K
Stem Cells; 1994 May; 12(3):329-38. PubMed ID: 7521243
[TBL] [Abstract][Full Text] [Related]
13. Purified unfractionated G-CSF/chemotherapy mobilized CD34+ peripheral blood progenitors and not bone marrow CD34+ progenitors undergo selective erythroid differentiation in liquid culture in the presence of erythropoietin and stem cell factor.
Pierelli L; Scambia G; Menichella G; Fattorossi A; Ciarli M; Bonanno G; Battaglia A; d'Onofrio G; Benedetti Panici P; Iacone A; Mancuso S; Leone G
Br J Haematol; 1997 Jan; 96(1):55-63. PubMed ID: 9012687
[TBL] [Abstract][Full Text] [Related]
14. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro.
Cipolleschi MG; D'Ippolito G; Bernabei PA; Caporale R; Nannini R; Mariani M; Fabbiani M; Rossi-Ferrini P; Olivotto M; Dello Sbarba P
Exp Hematol; 1997 Oct; 25(11):1187-94. PubMed ID: 9328456
[TBL] [Abstract][Full Text] [Related]
15. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha inhibits generation of glycophorin A+ cells by CD34+ cells.
Xiao W; Koizumi K; Nishio M; Endo T; Osawa M; Fujimoto K; Sato I; Sakai T; Koike T; Sawada Ki
Exp Hematol; 2002 Nov; 30(11):1238-47. PubMed ID: 12423676
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta 1 is an inducer of erythroid differentiation.
Krystal G; Lam V; Dragowska W; Takahashi C; Appel J; Gontier A; Jenkins A; Lam H; Quon L; Lansdorp P
J Exp Med; 1994 Sep; 180(3):851-60. PubMed ID: 7520475
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1.
Su S; Mukaida N; Wang J; Zhang Y; Takami A; Nakao S; Matsushima K
Blood; 1997 Jul; 90(2):605-11. PubMed ID: 9226160
[TBL] [Abstract][Full Text] [Related]
19. Haematopoietic action of flt3 ligand on cord blood-derived CD34-positive cells expressing different levels of flt3 or c-kit tyrosine kinase receptor: comparison with stem cell factor.
Sakabe H; Kimura T; Zeng Z; Minamiguchi H; Tsuda S; Yokota S; Hodohara K; Abe T; Lyman SD; Sonoda Y
Eur J Haematol; 1998 May; 60(5):297-306. PubMed ID: 9654159
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor.
Brada SJ; de Wolf JT; Hendriks D; Louwes H; van den Berg E; Vellenga E
Leukemia; 1998 Mar; 12(3):340-5. PubMed ID: 9529128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
